Xarelto will now be used to TREAT deep vein thrombosis (DVT)

Xarelto will now be used to TREAT deep vein thrombosis (DVT) in patients without a symptomatic pulmonary embolism.

Xarelto (rivaroxaban) is the first of the newer oral anticoagulants approved to treat DVT...Pradax (dabigatran) and Eliquis (apixaban) will likely follow.

Xarelto will be an alternative to using warfarin, low-molecular-weight heparin (LMWH), or unfractionated heparin for DVT.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote